Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by IGmmel, D. W.
Right arrow Articles by Rodriguez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by IGmmel, D. W.
Right arrow Articles by Rodriguez, M.
NEUROLOGY 1995;45:374-376
© 1995 American Academy of Neurology

Multifocal inflammatory leukoencephalopathy associated with levamisole therapy

David W. IGmmel, MD, Eelco F.M. Wijdicks, MD and Moses Rodriguez, MD

From the Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, MN.

Article abstract—cerebral demyelinating disease developed in a patient during adjuvant therapy with levamisole for malignant melanoma. This patient had no evidence of previous neurologic disease. Levamisole was administered for 5 weeks (total dose, 1,500 mg). Over a period of 3 weeks, the patient became progressively confused and ataxic. MRI with gadolinium enhancement demonstrated prominent multifocal enhancing white matter lesions. CSF examination revealed an inflammatory profile. After discontinuation of treatment with levamisole and a short course of corticosteroid therapy, the patient's condition dramatically improved. MRI also indicated improvement. Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5–fluorouracil and levamisole may have been caused at least partly by levamisole.




This article has been cited by other articles:


Home page
 NeurologyHome page
H. M. Liu, W. J. Hsieh, C. C. Yang, V. C. Wu, and K. D. Wu
Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers.
Neurology, September 26, 2006; 67(6): 1065 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Kumar, R. Orenstein, D. Z. Uslan, E. F. Berbari, C. J. Klein, and A. J. Windebank
Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis
Neurology, April 11, 2006; 66(7): 1120 - 1121.
[Full Text] [PDF]

Home page
 NeurologyHome page
D. A. Franco and H. S. Greenberg
5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency
Neurology, January 9, 2001; 56(1): 110 - 112.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. D. Recht and J. M. Primavera
Case 24-1999- Neurologic Disorder in a 65-Year-Old Man after Treatment of Colon Cancer
N. Engl. J. Med., August 12, 1999; 341(7): 512 - 519.
[Full Text] [PDF]